Next Article in Journal
Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants
Next Article in Special Issue
Protective Effect of Inactivated COVID-19 Vaccines against Progression of SARS-CoV-2 Omicron and Delta Variant Infections to Pneumonia in Beijing, China, in 2022
Previous Article in Journal
Recent Updates on mRNA Vaccines
Previous Article in Special Issue
Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study
 
 
Brief Report

Article Versions Notes

Vaccines 2022, 10(8), 1210; https://doi.org/10.3390/vaccines10081210
Action Date Notes Link
article xml file uploaded 29 July 2022 10:42 CEST Original file -
article xml uploaded. 29 July 2022 10:42 CEST Update https://www.mdpi.com/2076-393X/10/8/1210/xml
article pdf uploaded. 29 July 2022 10:42 CEST Version of Record https://www.mdpi.com/2076-393X/10/8/1210/pdf
article html file updated 29 July 2022 10:44 CEST Original file -
article html file updated 13 August 2022 04:27 CEST Update https://www.mdpi.com/2076-393X/10/8/1210/html
Back to TopTop